PT Kalbe Farma Tbk (PTKFY)
17.03
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
PT Kalbe Farma Price to Book Value: 2.793 for May 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 22, 2024 | 2.793 |
| May 21, 2024 | 2.793 |
| May 20, 2024 | 2.793 |
| May 17, 2024 | 2.793 |
| May 16, 2024 | 2.793 |
| May 15, 2024 | 2.793 |
| May 14, 2024 | 2.793 |
| May 13, 2024 | 2.793 |
| May 10, 2024 | 2.793 |
| May 09, 2024 | 2.793 |
| May 08, 2024 | 2.793 |
| May 07, 2024 | 2.793 |
| May 06, 2024 | 2.793 |
| May 03, 2024 | 2.793 |
| May 02, 2024 | 2.793 |
| May 01, 2024 | 2.793 |
| April 30, 2024 | 2.793 |
| April 29, 2024 | 2.836 |
| April 26, 2024 | 4.773 |
| April 25, 2024 | 4.773 |
| April 24, 2024 | 4.773 |
| April 23, 2024 | 4.773 |
| April 22, 2024 | 4.773 |
| April 19, 2024 | 4.773 |
| April 18, 2024 | 4.773 |
| Date | Value |
|---|---|
| April 17, 2024 | 4.773 |
| April 16, 2024 | 4.773 |
| April 15, 2024 | 4.773 |
| April 12, 2024 | 4.773 |
| April 11, 2024 | 4.773 |
| April 10, 2024 | 4.773 |
| April 09, 2024 | 4.773 |
| April 08, 2024 | 4.773 |
| April 05, 2024 | 4.773 |
| April 04, 2024 | 4.773 |
| April 03, 2024 | 4.773 |
| April 02, 2024 | 4.773 |
| April 01, 2024 | 4.773 |
| March 31, 2024 | |
| March 28, 2024 | 4.910 |
| March 27, 2024 | 4.910 |
| March 26, 2024 | 4.910 |
| March 25, 2024 | 4.910 |
| March 22, 2024 | 4.910 |
| March 21, 2024 | 4.910 |
| March 20, 2024 | 4.910 |
| March 19, 2024 | 4.910 |
| March 18, 2024 | 4.910 |
| March 15, 2024 | 4.910 |
| March 14, 2024 | 4.910 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.232
Minimum
Mar 23 2020
5.319
Maximum
Sep 10 2019
4.392
Average
4.544
Median
Jan 03 2023
Price to Book Value Benchmarks
| Taihe Group Inc | -- |
| CEL-SCI Corp | 4.922 |
| AIM ImmunoTech Inc | 5.088 |
| IGC Pharma Inc | 3.710 |
Price to Book Value Related Metrics
| PE Ratio | 21.18 |
| PS Ratio | 1.961 |
| Price | 17.03 |
| Earnings Yield | 4.72% |
| Market Cap | 3.939B |
| Operating PE Ratio | 16.31 |
| Normalized PE Ratio | 21.18 |